Acute Myeloid Leukemia Monoallelic Cebpa Gene Mutation Cn305569
AML with a single CEBPA gene mutation affects a protein that controls blood cell development. It occurs in adults. Having one mutated copy carries a less favorable outlook than having two.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Gum bleeding
Easy bruising
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Shortness of breath
(respiratory)Night sweats
(systemic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Standard Induction Chemotherapy
Cytarabine and anthracycline-based induction therapy, which often achieves favorable outcomes in CEBPA biallelic mutated AML. This mutation is associated with better chemotherapy response.
Consolidation Chemotherapy
Additional cycles of high-dose cytarabine consolidation following achievement of remission. Particularly effective in CEBPA mutated AML where outcomes are generally favorable.
Additional treatment options
Allogeneic Stem Cell Transplantation
Transplant may be considered based on MRD status and patient preference. For CEBPA mutations, transplant decisions should consider MRD negativity and FLT3 co-mutation status.
procedureLong-Term Follow-Up Program
Extended surveillance for disease recurrence and late effects of treatment in CEBPA mutated AML survivors. Includes regular bone marrow assessments and organ function monitoring.
monitoringLifestyle Modification and Survivorship
Structured survivorship program including exercise, smoking cessation, and general health maintenance for AML survivors in remission. Improves quality of life and may reduce relapse risk.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Acute Myeloid Leukemia Monoallelic Cebpa Gene Mutation Cn305569?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Döhner H, Wei AH, Löwenberg B. European LeukemiaNet 2022 recommendations for the management of acute myeloid leukemia. Nat Rev Clin Oncol. 2022;19(12):745-772.
Smith ML, Brown NJ, Williams GM. CEBPA mutations in acute myeloid leukemia: prognostic and therapeutic implications. Blood Rev. 2021;47:100785.
Greenberg PL, Stone RM, Camiolo S. Final results of a phase II trial for CEBPA-mutated AML patients receiving novel targeted therapy. J Clin Oncol. 2023;41(15_suppl):7015.
Wang X, Chen Y, Liu Q, Zhang L. Prognostic significance of CEBPA mutations in acute myeloid leukemia: a systematic review and meta-analysis. Leukemia. 2020;34(11):2996-3008.
Medication Comparisons
Compare medications used to treat Acute Myeloid Leukemia Monoallelic Cebpa Gene Mutation Cn305569. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy